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Aciculin is a recently identified 60-kDa cytoskeletal 
protein, highly homologous to the glycolytic enzyme 
phosphoglucomutase type 1, (Belkin, A. M., Kliman· 
skaya, I. V., Lukashev, M. E., Lilley, K., Critchley, D., and 
Koteliansky, V. E. (1994) J. Cell Sci. 107, 159-173). Acicu-
lin expression in skeletal muscle is developmentally reg-
ulated, and this protein is particularly enriched at cell-
matrix adherens junctions of muscle cells (Belkin, A. M., 
and Burridge, K. (1994) J. Cell Sci. 107, 1993-2003). The 
purpose of our study was to identify cytoskeletal pro-
tein(s) interacting with aciculin in various cell types. 
Using immunoprecipitation from celllysates of metabol-
ically labeled differentiating C2Cl2 muscle cells with 
anti-aciculin-specific antibodies, we detected a high mo-
lecular weight band (Mr - 400,000), consistently copre-
cipitating with aciculin. We showed that this 400 kDa 
band comigrated with dystrophin and immunoblotted 
with anti-dystrophin antibodies. The association be-
tween aciculin and dystrophin in C2C12 cells was shown 
to resist Triton X-100 extraction and the majority of the 
complex could be extracted only in the presence of ionic 
detergents. In the reverse immunoprecipitation experi-
ments, aciculin was detected in the precipitates with 
different anti-dystrophin antibodies. Immunodepletion 
experiments with lysates of metabolically labeled C2C12 
myotubes showed that aciculin is a major dystrophin-
associated protein in cultured skeletal muscle cells. 
Double immunostaining of differentiating and mature 
C2C12 myotubes with antibodies against aciculin and 
dystrophin revealed precise colocalization of these two 
cytoskeletal proteins throughout the process of myodif-
ferentiation in culture. In skeletal muscle tissue, both 
proteins are concentrated at the sarcolemma and at 
myotendinous junctions. In contrast, utrophin, an auto-
somal homologue of dystrophin, was not codistributed 
with aciculin in muscle cell cultures and in skeletal 
muscle tissues. Analytical gel filtration experiments 
with purified aciculin and dystrophin showed interac-
tion of these proteins in vitro, indicating that their as· 
sociation in skeletal muscle is due to direct binding. 
Whereas dystrophin was shown to be a major aciculin· 
associated protein in skeletal muscle, immunoblotting 
of anti-aciculin immunoprecipitates with antibodies 
against utrophin showed that aciculin is associated with 
utrophin in cultured A7r5 smooth muscle cells and 
REF52 fibroblasts. Immunodepletion experiments per-
formed with lysates of metabolically labeled A 7r5 cells 
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demonstrated that aciculin is a major utrophin-binding 
protein in this cell type. Taken together, our data show 
that aciculin is a novel dystrophin- and utrophin-bind-
ing protein. Association of aciculin with dystrophin 
(utrophin) in various cell types might provide an 
additional cytoskeletal-matrix transmembrane link at 
sites where actin filaments terminate at the plasma 
membrane. 
Dystrophin is the largest ( -427 kDa) member of the o:-acti-
nin/spectrin/dystrophin superfamily of cytoskeletal proteins, 
originally identified as the gene product absent in Duchenne's 
(or altered in Becker's) muscular dystrophy (1, 2). Dystrophin 
is a flexible elongated protein, which consists of four distinct 
domains, including: 1) an N-terminal actin-binding domain 
with homology to o:-actinin, spectrin, and filamin, 2) a large 
central rod domain, containing 24 spectrin-like repeats, 3) a 
cysteine-rich domain, homologous to the o:-actinin C terminus, 
and 4) a C-terminal domain of 420 amino acids without any 
significant homology outside the dystrophin subfamily (3, 4). 
Utrophin, an autosomal homologue of dystrophin, is a high 
molecular mass ( -395 kDa) cytoskeletal protein, consisting of 
the same four domains, as dystrophin (5-7). The N-terminal 
actin-binding domain, cysteine-rich and C-terminal domains 
are particularly highly conserved between these two proteins, 
whereas the sequence homology in the central rod domain, 
containing spectrin-like repeats, is relatively low (5-7). 
Recent data have demonstrated the existence of multiple 
dystrophin-like proteins in different tissues, including skeletal 
muscle (5-11). Full-length forms of the dystrophin subfamily 
include dystrophin itself (3), which is synthesized in all three 
muscle types and in brain (1, 12-14), and the ubiquitously 
expressed utrophin (formerly referred to as dystrophin-related 
protein), encoded by a separate gene (5-7, 15, 16). Also, there 
are several shorter forms in the dystrophin subfamily, such as 
the 87-kDa phosphoprotein from Torpedo electric tissue (17), 
partially homologous to dystrophin (11) and a 71-75-kDa short 
form(s), that arises by use of an alternative internal promoter, 
lying between exons 62 and 63 of the dystrophin gene (8, 9, 18, 
19). Finally, numerous alternatively spliced transcripts of the 
extremely large, 65 exon-containing dystrophin gene yield mul-
tiple dystrophin isoforms with different C-terminal domains 
(20-22). 
Dystrophin as well as utrophin are particularly enriched at 
neuromuscular junctions of skeletal muscle (23-26). Unlike 
utrophin, dystrophin is also localized at the sarcolemma of 
normal muscle (27-30), more specifically, in a costamere-like 
subsarcolemmal lattice (31, 32) and is enriched at myotendi-
nous junctions (33). In cultured differentiating muscle cells, 
dystrophin is transiently localized to focal adhesions (34). In 
contrast with the tissue-specific expression of dystrophin, utro-
phin was found in all tissues examined so far (5-7, 15, 16, 35). 
Smooth muscle tissues and cells, particularly vascular smooth 
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muscle cells, produce the largest amounts of utrophin (16).
Among the various types of cultured cells, utrophin was iden-
tified in primary cultures of neurons and glia (16), proliferating
brain cell lines, HeLa cells, smooth muscle-like BCaH1 cells,
COS cells, P388D1 monocyte-macrophage cells, and in cultures
of untransformed human skin fibroblasts (16, 36).
Dystrophin interacts with F-actin at its N terminus (3, 4,
37-40). The C-terminal tail of the molecule, which is particu-
larly conservative (12, 41, 42), represents a site of membrane
attachment (43, 44). In skeletal and cardiac muscles, dystro-
phin is associated with several proteins, including a 59-kDa
peripheral membrane proteints), three sarcolemmal glycopro-
teins with molecular masses 50, 43, and 35 kDa, a 25-kDa
transmembrane protein, and a 156-kDa laminin-binding extra-
cellular proteoglycan, termed o-dystroglycan. All together the
complex provides a transmembrane cytoskeletal-matrix link-
age in muscle tissues (39, 43, 45-47). In skeletal muscle, utro-
phin is also associated with a complex of sarcolemmal proteins,
antigenically indistinguishable from the components of the
dystrophin-glycoprotein complex (48). All the major dystro-
phin-associated proteins are drastically decreased in dystro-
phic muscle (49, 50), indicating that dystrophin stabilizes the
entire transmembrane complex (51). Among these dystrophin-
associated proteins, the 59-kDa protein is thought to bind dys-
trophin directly, presumably near its C terminus (43, 44, 46).
The 59-kDa cytoplasmic dystrophin-associated component of
the dystrophin-glycoprotein complex is represented by a closely
disposed triplet (43,46,47). This is composed of a lower band
(named 59-1 DAP)l that is structurally and functionally ho-
mologous to a previously described dystrophin-associated,
postsynaptic 58-kDa protein (syntrophin), In addition, two un-
related proteins make up the higher bands of the triplet (52-
56). Two different mRNAs encode two structurally distinct
syntrophin forms, having drastically different tissue expres-
sion patterns (54). Other members ofthe dystrophin subfamily,
including utrophin and the short C-terminal forms of dystro-
phin also interact with syntrophin (55). Even though the inter-
action between different dystrophin forms and the 59-kDa pe-
ripheral membrane proteints) is apparently playing a key role
in their membrane association in skeletal muscle (50, 51, 55),
some other dystrophin-binding proteins associated with vari-
ous dystrophin forms may exist. This prediction is based
mainly on the fact that multiple dystrophin variants, differing
in their C-terminal domains, arise by a selective removal of
exons at three splice junctions from dystrophin pre-mRNA (20).
Notably, these alternatively spliced transcripts of the dystro-
phin gene were detected in several tissues, including skeletal
muscle itself (12, 20, 23). This important observation points to
a potential existence of several different dystrophin-binding
proteins, interacting with the C-terminal domain of various
alternatively spliced forms of dystrophin (20). Nevertheless,
until now, the 59-kDa DAP (syntrophin) remains the only char-
acterized dystrophin-binding protein, interacting with the dys-
trophin C-terminal domain (43, 47, 52-56).
Aciculin is a recently identified component of the peripheral
membrane cytoskeleton in muscle and some nonmuscle cells
(57). This 60/63-kDa phosphoglucomutase type-1 (PGM1)-re-
lated cytoskeletal protein is enriched in all three muscle types,
where its expression is developmentally regulated and differ-
entiation-dependent (57, 58). In skeletal muscle, aciculin is
concentrated at different types of cell-matrix adherens june-
1 The abbreviations used are: DAP, dystrophin-associated proteins;
PAGE, polyacrylamide gel electrophoresis; mAb, monoclonal antibody;
PBS, phosphate-buffered saline; RIPA buffer, radioimmunoprecipita-
tion buffer; PGM1, phosphoglucomutase type 1; PIPES, 1,4-pipera-
zinediethanesulfonic acid.
tions, such as myotendinous junctions and costameres, and is
localized to focal adhesions of differentiating myotubes in cul-
ture (58). Here we present data showing that this newly de-
scribed cytoskeletal protein interacts with dystrophin in skel-
etal muscle and is associated with utrophin in smooth muscle
cells and fibroblasts.
EXPERIMENTAL PROCEDURES
Materials-Except where otherwise stated, materials were pur-
chased from Sigma.
Antibodies-Anti-aciculin-specific mAb XIVF8 and polyclonal anti-
bodies against aciculin, cross-reacting with PGM1, were described pre-
viously (57,58). Anti-dystrophin mAbs NCL-Dys1, recognizing the cen-
tral rod domain of dystrophin and NCL-Dys2, raised against the last 17
amino acids of dystrophin and anti-utrophin mAb NCL-DRP1, reacting
with the last 11 amino acids at the C terminus of utrophin, were from
Novocastra Laboratories (Newcastle upon Tyne, United Kingdom).
Anti-dystrophin mAb 1808 against Torpedo dystrophin, cross-reacting
with mammalian dystrophin, anti-dystrophin mAb 1958, reacting with
avian dystrophin, and mAb 1351 against the 58-kDa post-synaptic
dystrophin-binding protein (syntrophin) were gifts from Drs. S.
Froehner and R. Sealock (24). Rabbit polyclonal antibody raised against
a dystrophin fusion protein, representing the 60-kDa N-terminal seg-
ment of the molecule, was a gift from Dr. E. Hoffmann (2). Anti-vinculin
mAb VIIF9 was previously shown to react with mouse vinculin and
metavinculin (57, 58). For preadsorbtion experiments and immunoaf-
finity purification of corresponding antigens anti-aciculin mAb XIVF8
and anti-dystrophin mAb 1958 were coupled to cyanogen bromide-
activated Sepharose 4B (10 mg/ml of resin) by conventional methods.
Cell Cultures-C2C12 mouse skeletal muscle myocytes were pur-
chased from the American Type Culture Collection (Rockville, MD) and
cultured as described earlier (58). Cells were cultured either on gelatin-
coated plastic dishes for subsequent biochemical experiments or on
laminin-coated coverslips for immunofluorescent staining. A7r5 rat em-
bryonic thoracic aorta smooth muscle cells were obtained from the
American Type Culture Collection and cultured in Dulbecco's modified
Eagle's medium containing 10% fetal bovine serum. Rat embryonic
fibroblasts (REF52) were grown in Dulbecco's modified Eagle's medium
supplemented with 10% fetal bovine serum.
Metabolic Labeling and Immunoprecipitation-CuItured C2C12
mouse myocytes, taken at different stages of myodifferentiation, were
metabolically labeled with 0.1 mCilml of Translabel (a mixture of
[35SJmethionine and [35SJcysteine, ICN Biomedicals, Irvine, CAl in
methionine-, cysteine-free medium for 4 h at 37 DC. After the labeling,
cells were washed four times with PBS (137 mMNaCl, 3 mMKCl, 10 mM
NazHP04 , 2 mMKH 2P04 , pH 7.5) and lysed on ice for 3 min with RIPA
buffer (50 mM TrisCl, 150 mM NaCl, 1 mM EDTA, 1 mx EGTA, 1%
Triton X-IOO, 0.5% sodium deoxycholate, 0.1% SDS, pH 7.5, containing
protease inhibitors, 1 mM phenylmethylsulfonyl fluoride, 1 mM benza-
midine, 10 J.Lg/ml leupeptin, and 10 J.Lg/ml aprotinin). To equalize the
total amounts of de novo synthesized proteins in different cell samples,
2-J.Ll aliquots of each sample were counted in an LS5000CE scintillation
counter (Beckman, Palo Alto, CAl and equal amounts of total incorpo-
rated 35S radioactivity (2 X 108 counts/min/sample) were taken for
subsequent immunoprecipitations.
Cell lysates were precleared by spinning at 15,000 x g for 15 min at
4 DC, and all the subsequent incubations were done at 4 DC on a rotator.
35S-Labeled cell lysates were preincubated for 1 h with 100 J.Ll of 20%
suspension of Protein A-Sepharose beads, and supernatants were incu-
bated for 2 h with primary anti-aciculin antibodies (XIVF8 mAb or
polyclonal anti-aciculin antibody) and then for 1 h with 100 J.Ll of 20%
bead suspension of Protein A-Sepharose. Immune complexes were ex-
tensively washed with the ice-cold RIPA buffer, then with PBS (once),
and finally boiled in 30 J.Ll of SDS electrophoretic sample buffer for
5 min.
To estimate protein partitioning between Triton-soluble (not associ-
ated with cytoskeleton) and Triton-insoluble ("cytoskeletal") fractions of
cultured C2C12 cells, cultures of differentiated myotubes were sequen-
tially extracted on ice for 3 min, first with 0.5% Triton X-100 in 100 mM
potassium-PIPES, 1 mMMgC12, 1 mM EGTA, pH 7.0, containing prote-
ase inhibitors, and then with RIPA buffer supplemented with protease
inhibitors (as above).
For the comigration experiment with aciculin and dystrophin, we
immunoprecipitated dystrophin from 35S-labeled C2C12 myotubes un-
der denaturing conditions. To do this, we precipitated both Triton X-100
-soluble and Triton X-IOO-insoluble fractions of C2C12 myotubes with
ice-cold acetone. Protein precipitates were spun down, dried, redis-
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solved in 100 /LI of 1% SDS, and boiled for 3 min. Then, both 55S-labeled
celllysates were reconstituted up to 1 ml volume (final SDS concentra-
tion 0.1%) with 1% Triton X-100 in 50 mMTrisCI, 150 mM NaCI, pH 7.5,
and subsequently used for immunoprecipitation with anti-dystrophin
antibodies.
To analyze the potential association of aciculin with dystrophin
(utrophin) in C2C12 cells, Triton X-100-soluble and -insoluble fractions
of unlabeled differentiated C2C12 myotubes were subjected to immu-
noprecipitation with antibodies against aciculin (XIVF8 mAb), dystro-
phin (NCL-Dys1 mAb), or utrophin (NCL-DRP1 mAb), as described
above, except that rabbit anti-mouse IgG (Chemicon, Temecula, CAl
conjugated to Protein A-Sepharose was used for immunoprecipitation
with anti-dystrophin and anti-utrophin mAbs. 3 x 100-mm dishes of
differentiated C2C 12 myotubes were taken for immunoprecipitation
with each antibody. Corresponding immunoprecipitates were washed,
boiled in SDS, and run on SDS-polyacrylamide gels. Protein bands were
transferred to Immobilon membranes (Millipore, Bedford, MA) and
probed with antibodies against aciculin or dystrophin.
To detect whether aciculin interacts with utrophin in some other cell
types outside skeletal muscle, cultures of A7r5 smooth muscle cells,
REF52 fibroblasts as well as C2C12 myotubes were lysed in RIPA
buffer containing protease inhibitors (as above) and subjected to immu-
noprecipitation with XIVF8 anti-aciculin mAb. Immunoprecipitates
were washed several times with RIPA buffer, then with PBS, boiled in
SDS sample buffer, and subjected to electrophoresis and subsequent
immunoblotting (59, 60) with antibodies against aciculin, dystrophin,
and utrophin. An extract of 2 g of bovine heart muscle tissue in 20 ml
of 1% Triton X-100, 20 mM TrisCI, 0.5 M NaCI, pH 7.4, containing
protease inhibitors, was used for immunoprecipitation of aciculin, dys-
trophin, and utrophin as a positive control for the presence of these
proteins in various cell cultures.
Immunodepletion Experiments-To examine whether aciculin is a
major dystrophin-associated protein in cultured C2C12 cells, immu-
nodepletion experiments with RIPA extracts of 55S-labeled C2C12 myo-
tubes were performed. To remove the majority of aciculin before the
subsequent immunoprecipitation, anti-aciculin XIVF8 mAb, coupled to
Sepharose 4B, was used for preincubation with an 55S-labeled cell
lysate. A precleared RIPA extract of 10 X 60-mm dishes of differenti-
ated C2C12 myotubes was divided into two equal parts. Half was
preadsorbed (2 h at 4°C on the rotator) with 2 mg of XIVF8 mAb,
coupled to Sepharose resin, and the other half with unconjugated
Sepharose 4B. The resulting supernatants were immunoprecipitated in
parallel with XIVF8 anti-aciculin mAb, NCL-Dys1 anti-dystrophin
mAb, NCL-DRP1 anti-utrophin mAb, mAb 1351 against 58-kDa protein
(syntrophin), and VIIF9 anti-vinculin mAb, following rabbit anti-mouse
IgGlProtein A-Sepharose. The resulting immune complexes were
washed, boiled in SDS, and subjected to electrophoresis.
To analyze further aciculin-utrophin association in cultured A7r5
smooth muscle cells, aciculin immunodepletion experiment was also
performed with RIPA extracts of 55S-labeled A7r5 cells, using the
method described above. In this case aciculin-depleted and control
35S-labeled celllysates were used in parallels for immunoprecipitation
with XIVF8 anti-aciculin mAb, NCL-DRP1 anti-utrophin mAb, and
anti-syntrophin mAb 1351.
Immunoaffinity Purification of Dystrophin-Stripped membranes
obtained from 100 g of chicken gizzard smooth muscle were prepared as
described earlier by Kelly et al. (61). The final pellet, containing mostly
integral membrane and membrane-associated proteins, and lacking
most of the actin, actin-binding cytoskeletal proteins, and myosin, was
extracted for 4 h at 4 °C with 600 ml of 1% Triton X-100, 20 mM TrisCI,
0.5 M NaCI, 1 mM EDTA, 1 mM EGTA, pH 7.4, containing protease
inhibitors 0.5 mM phenylmethylsulfonyl fluoride, 0.5 mx benzamidine,
1 ug/ml leupeptin, and 1 /Lg/ml aprotinin. The detergent extract of
smooth muscle tissue was spun down at 10,000 x g for 30 min and
prefiltered through a Sepharose 4B column. The resulting precleared
supernatant was applied to a column containing anti-dystrophin 1958
mAb immobilized on Sepharose 4B. The column was sequentially
washed with 10 column volumes of 0.1 % Triton X-lOOin 1.5 MNaCI, 50
mM TrisCI, 1 mM EDTA, 1 mM EGTA, pH 7.4, then with 10 volumes of
0.1% Triton X-100 in 100 mM NaCI, 50 mM TrisCI, 1 mM EDTA, 1 mM
EGTA, pH 9.5, and finally eluted with 2.5 column volumes of 0.1%
Triton X-100 in 50 mM triethanolamine, pH 11.5. All column buffers
contained 2 mM phenylmethylsulfonyl fluoride, 2 mM benzamidine, 25
/Lg/mlleupeptin, and 25 /Lg/mlpepstatin as protease inhibitors. The pH
in the final pH 11.5 eluate was immediately readjusted to 7.5 with 1 M
HCI, and the eluate was extensively dialyzed against 0.1% TritonX-100
in 10 mMTrisCI, 10 mM NaCI, pH 7.5, at 4°C. The pH 11.5 eluate from
the anti-dystrophin immunoaffinity column, containing ~70-80% pure
dystrophin and some minor bands, representing copurifying proteins
and/or dystrophin proteolytic fragments, was concentrated in Centricon
microconcentrators (Amicon), applied onto a HR 10/30 Superose 6 fast
protein liquid chromatography gel-filtration column (Pharmacia,
Sweden), and eluted with 10 mMTrisCI, 50 mMNaCI, 1 mMEDTA, 1 mM
EGTA, pH 7.5, containing protease inhibitors. Dystrophin was mostly
separated from low molecular weight contaminants on the column, and
fractions containing -90% pure dystrophin were concentrated in mi-
croconcentrators and used for analytical gel-filtration experiments with
aciculin.
Aciculin Purification-Aciculin was purified from human uterus
smooth muscle as described previously (57), except that the hydroxyl-
apatite column chromatography step was omitted and gel filtration on
a 2.5 x 100-cm Sephacryl S-300 (Pharmacia) column was used as a
second chromatography step and an fast protein liquid chromatography
monoQ anion-exchanger column (Pharmacia) was used as a final puri-
fication step.
Analytical Gel Filtration-Gel filtration binding studies were per-
formed using a high resolution analytical Superose 6 10/30 column
(Pharmacia). Electrophoresis and subsequent immunoblotting of col-
umn fractions was performed as described by Crawford et al. (62).
Purified aciculin and dystrophin were dialyzed against 10 mM TrisCI,
50 mM NaCI, 1 mM EDTA, and 1 mM EGTA, pH 7.5, with protease
inhibitors and precleared by centrifugation in a Microfuge (Beckman)
for 15 min at 12,000 revolutions/min. Aciculin was mixed with dystro-
phin and incubated 1 h on ice before the column run. Sequential gel
filtration runs were aciculin alone (20 /Lg in 200 /LI of buffer), a mixture
of 20 /Lg of aciculin and 10 /Lg of dystrophin, and a mixture of 20 /Lg of
aciculin and 50 /Lg of dystrophin. 300-/LI fractions were collected for
these three runs, and 30-/LIaliquots ofthe column fractions were mixed
with SDS sample buffer, boiled for 5 min, and run on 10% polyacryl-
amide gels. Proteins were transferred onto Immobilon membranes and
probed with anti-aciculin mAb XIVF8 and anti-dystrophin 1958 mAb.
SDS-Polyacrylamide Gel Electrophoresis and Immunoblotting-For
electrophoresis of 35S-labeled proteins, 10% polyacrylamide gels, con-
taining 0.13% bisacrylamide, were used (59). After electrophoresis, gels
were fixed in 25% methanol, 10% acetic acid, treated with Amplify
(Amersham Corp.) for 30 min, dried, and exposed to x-ray film (East-
man Kodak Co.) for 36-72 h at -70°C to detect 55S-labeled protein
bands. Unlabeled proteins were visualized in gels by Coomassie Blue
staining. To enhance the electrotransfer of high molecular weight pro-
teins, 5-12% acrylamide (40:1 ratio of acrylamide/bisacrylamide) gels
were used for immunoblots with anti-dystrophin or anti-utrophin anti-
bodies. Proteins were transferred onto Immobilon membranes in 25 mM
TrisCI, 192 mM glycine, 20% methanol, pH 8.3, for 40 h at 0.5 A and
then 3 h at 1 A (60). Blots were blocked with 2% bovine serum albumin,
2% cold fish gelatin, 0.1% Tween 20 in TBS (50 mM TrisCI, 150 mM
NaCI, pH 7.5) for 1 h. Then blots were incubated with anti-aciculin
XIVF8 mAb, anti-utrophin NCL-DRP1 mAE, or a mixture ofNCL-Dys1,
NCL-Dys2, and 1808 mAb for detection of dystrophin. Rabbit anti-
mouse affinity-purified IgG, conjugated with peroxidase (Jackson, West
Grove, PA), diluted 1:10,000, was used as secondary antibody. Blots
were extensively washed in TBS plus 0.1% Tween 20, then with TBS
and finally developed using ECL reagents (Amersham),
Immunofluorescence-For immunostaining of C2C12 cells, muscle
cells growing on laminin-coated glass coverslips, taken at various
stages of myogenic differentiation, were fixed for 5 min with ice-cold
absolute methanol. For simultaneous detection of aciculin and dystro-
phin in cultured muscle cells, coverslips were incubated with rabbit
polyclonal anti-aciculin antibody and a mixture of anti-dystrophin
mAbs NCL-Dys1, NCL-Dys2, and 1808, followed by incubation with
fluorescein-labeled goat anti-rabbit IgG and rhodamine-labeled donkey
anti-mouse IgG (Chemicon).
For immunofluorescent staining of muscle tissue sections, 5-8-/Lm
cryosections of rabbit adult or chicken 18-day embryonic thigh skeletal
muscle tissues were fixed for 5 min in ice-cold methanol and then
postfixed with acetone. Cryosections were treated with XIVF8 anti-
aciculin mAb, NCL-DRP1 anti-utrophin mAb, 1958 anti-dystrophin
mAb for chicken tissue or mixture of NCL-Dys1, NCL-Dys2, and 1808
anti-dystrophia mAbs for rabbit tissues. Stained C2C12-cultured mus-
cle cells and muscle tissue sections were mounted in Mowiol medium
and examined on a Zeiss Axiophot microscope equipped with epifluo-
rescence. Fluorescence micrographs were taken on T-max 400 film
(Eastman Kodak).
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F!G. 1. Id e ntification of aciculm-b inding proteins in d ifferen-
tiating C2C 12 cells by m etabolic labeling and immunoprecipi-
tation . C2C12 myogenic cells, cultured for 3 days (a), 5 day s (b), 7 days
(c), 10 days (d) , 12 days (e) , and 14 days (fI, wer e metabolically lab eled
with [35Slmethioninel[35Slcystein e a nd 35S-la beled celllysates in RIPA
buffer were used for immunoprecipitation with anti-aciculin mAb
XIVF8 (A) or polyclon al a nti-aciculin antibodies (E). Immunoprecipi-
tates were wash ed and run on 10% SDS-polyacrylamide gel. Positions of
molecul ar ma ss marker proteins a re indicated in kilod altons to the left
of th e ge l (A) . Large arro wheads indi cate acicu lin in A a nd B , a nd th e
sm all arrowh ead marks th e positi on of PGMI in B. Arro ws to th e right
of both gels point to a high molecul ar weight protein (M; - 400 ,000 ),
consistently coprecipitating with ac iculin in C2C l 2 cell s.
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from 'I'riton X-lOO-soluble an d -insol uble fractions ofC2C12 myo-
tubes (Fig. 2C, c an d d ). Similar immunoblotting experiments
performed with ut rophin imm unop recipitates revealed much less
aciculi n associated with the dystrophin homologue in differ enti-
ated C2C12 (Fig. 2D, c and d ). It should be noted, that in some
experiments, we were not able to detect any aciculin in utrophin
immunoprecipitates from C2C12 cells. Immunoprecipitating
other major actin-associated cytoskeletal proteins, such as vin-
culin or o-actinin, from C2C12 myotubes and subsequent immu-
noblotting of these immunoprecipitates with anti-aciculin anti-
bodies did not reveal any aciculin in association with these
proteins (data not shown), pointing to specificity in the aciculin
and dystrophin immunoprecipitates.
To explore further the interaction between aciculin and dys-
trophin in C2C12 muscle cells , several anti -dyst rophi n anti bod-
ies were used in immunoprecipitation experiments with RIPA
extracts of C2C12 myotubes, followed by immunoblot of th ese
immunoprecipitates with XIVF8 ant i-aciculin mAb (Fig. 3).
In terestingly, polyclonal antibodies against th e N-terminal 60-
kDa fragment of dystrophin rev ealed th e largest amounts of
aciculin in anti-dystrophin immunoprecipitates. Th e levels of
acic ulin in these immunoprecipitates were comparable to those
foun d in anti-aciculin immunoprecipitates (Fig. 3, a and e).
Im munoprecipit ates wit h NCL -Dysl mAb, which recognizes an
epito pe in the central rod domain of dystrophi n, gave a weaker,
but still easily detectable reaction wit h anti -aciculin (Fig. 3b).
When we used NCL-Dys2 mAb, which is directed aga inst the
last 17 amino acids of dyst rophin, or NCL-DRP I mAb, which
FIG.2. Ac ic u li n is a ssociated w ith dystrophin in c u ltured
C2C12 myotubes . A , comigr ation experiment with anti-aciculin a nd
anti-dystrophin imm unoprecipitates. C2Cl 2 cell s, cultured for 10 days,
were metabolically labeled with [35Slmethionine/[35S1cystein e and lysed
sequentially in Triton X-IOO(a a nd c) a nd th en in RIPA buffer ib and d ).
Corresponding 35S-labeled lysates wer e immunopr ecipi tated with
XIVF8 a nti-aciculin mAb (a and b ) or with NCL-Dysl a nti-dys trophin
mAb (c a nd d ). Dystrophin immunoprecipitation from both Triton
X-IOO-solubl e a nd -insoluble fractions ofC2Cl2 myotubes (c a nd d ) was
done under den aturing conditions (see "Experi me ntal Procedures").
Immunopr ecipitates were wash ed a nd run on 10% SDS-polyacrylamide
gel. Note comigration of a high molecul ar weight protein , copreci pitat-
ing with aciculin from th e Triton-insolubl e ("cytoskeleta l") fraction of
C2C l 2 myotubes, with dystrophin. B-D, associ at ion of aciculin wit h
dystroph in (u trophin) in C2C l 2 myotubes . Tri ton X-I OO-soluble (a and
c) a nd -insoluble (b and d ) fractions of differentiated C2Cl2 myotubes
wer e subjecte d to immunoprecipitation with a nti-aciculin XIVF8 mAb
(B·D , a and b), a nti-dys t rophin NCL-Dysl mAb (B a nd C, c an d d ), or
a nti -ut rophi n NCL-DRPI mAb (D , c a nd d). Immunopr ecipitates wer e
washed exte nsively a nd run on 5-12% (B ) or 10% (C a nd D ) SDS ·
polyac rylamide gels . Proteins were t ran sferred to Immobilon mem -
bra ne, a nd blots wer e probed with antibodies to dystrophin (mixture of
NCL-Dysl , NCL-Dys2 , a nd 1808 mAbs in B ) or an ti -aciculin XIVF
mAb (C a nd D). Immunoglobulin heavy cha ins are shown by arrowhead
to th e left of th e gels (B and C). Dystrophin immunoreactive bands are
indi cated by th e short arrow in B; aciculin bands a re indicated by the
long arro w in C and D. Positions of molecular ma ss mark ers in kilodal-
tons are given to th e left of each gel.
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RESULTS
In order to detect any proteins that are potentially associated
with aciculin in muscle cell s, cultured C2C12 myocytes taken
at various stages of myogenic differentiation were metaboli-
ca lly labele d with [35S1methionine/[35S1cysteine, lysed in RIPA
buffer , a nd cell lysates were subjected to immunopreci pitation
with either mAb XIVF8, specific to aciculin, or polyclonal anti-
ac iculin antibodies . Besides acic ulin itself (a - 60 kDa band in
immunoprec ipitates with eithe r monoclonal or polyclonal anti-
bodies ) and PGMI (a - 64 kDa band with polyclonal anti-
ac iculi n antibodies ), several additional ba nds were found in
both ty pes of immunoprecipitates (Fig. 1). Among these addi-
tional bands, a high molecular weight band tM ; - 400 ,000 ) was
consistently present in precipitates with mAb XIVF8 and poly-
clonal anti-aciculin antibodies (a r row in Fig. 1, A and B ). This
band was much more prominent in differentiated C2C12 cells,
expressing higher amounts of aciculin (Fig. lA , lan es d-]; lB ,
lan es b-f) , but was barely detectable in early myoblast cultures
(Fig. lA , a- c; lB, a ).
In an attempt to identify thi s high molecular weight aciculin-
associated protein, we compared th e migration of this band with
dystrophin. Aciculin and dystrophin were immunoprecipitated
from Triton X-lOO-soluble and -insoluble fractions of 35S-labeled
terminally differentiated C2C12 myotubes (Fig. 2A). The high
molecular weight aciculin-associated protein, enriched in the Tri-
ton X-lOO-insoluble ("cytoskeletal") fraction of cultured myo-
tubes, comigrated with dystrophin (Fig. 2A, bod). Imrnunoblot-
ting of corresponding unlabeled immunoprecipitates from
differen tiated C2C12 myotubes with antibodies aga inst dystro-
phin showed that this protein represents dyst rophin (Fig. 28).
Notably, the majority of the complex was resistant to the Tri ton
X-lOO ext raction, showing its as sociation with the cytoskeleto n
(Fig. 28, a and b). In the conve rse experi ment, aciculin was
detected by immunoblot in anti-dystrophin immunoprecipitates
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FIG. 3. Aciculin is present in immunonoprecipitates with dif-
ferent anti-dystrophin antibodies. C2C 12 myotubes were taken on
the 10th day of culture, lysed in RIPA buffer , and cell lysates were
immunoprecipitated wit h: polyclonal anti -dys trophin anti body, ra ised
ag a ins t 60-kDa N-terminal fragment of dystroph in (a ), mAb NCL-Dys 1
(b), mAb NCL-Dys2 aga inst dystrophin (c), mAb NCL-DRP1 agains t
ut rophin (d) , and mAb XIVF8 to aciculin (e ). Immunoprecipitates were
exte nsively washed wit h RIPA buffer, run on 10% SDS-polyacrylamide
gel, and blotted wit h anti-aciculin XIVF8 mAb. Arrow indicat es the
position of aciculin. A rrowh ead shows immunoglobulin heavy chain s.
Posit ions of molecular mass markers a re indicated in kiloda lton s to the
left of the gel.
binds the 11 most C-te rmina l amino acids in utrophin, aciculin
was only barely detectable (Fig. 3, c and d ).
To an alyze if aciculin is, ind eed , a major dystrophin-binding
pr otein in differ en tiated C2C 12 mus cle cells , aciculin immu-
nodepletion experime nts were perform ed wit h RIPA ext racts of
3f>S-labeled C2C 12 myotubes. 3f>S-Labeled cell extracts, pr ead -
sor bed with anti-ac iculin XIVF8 mAb, coupled to Sepharose 4B,
and control extra cts , pr ein cub ated with unconjugated Sepha-
rose 4B, were used for subse quent immunoprecipitation with
antibodies against aciculin , dystrophin , utrophin, 58-kDa pro-
tein (syntrophin), and anti-vinculi n as a control an tib ody.
Overexposed autora diographs were used to detect th e whole
spect rum of protein s, as socia ted with aciculin , dystrophin , a nd
utroph in in cultured C2C 12 myotubes (Fig. 4). A majority of
aciculin was depleted from C2C12 cell ext racts by pr eadsorb-
tion with XIVF8 mAb-Sepharose (Fig. 4, arrow, lanes a and a' ).
Notably, a maj or - 60 kDa band, presen t in both anti-dystro-
phin and anti-ut rophin immunopr ecipi tates (Fig. 4, b' and c') ,
was cons ide rably diminish ed in th ese immunopre cipitates af-
te r pr eincubation with anti-ac iculin-Se pharose (Fig. 4, b and c) .
A large cluster of bands around 52-60 kDa was seen in an ti-
syntrophin immunopr ecipitates , bu t these bands were not de-
pleted by the pr eincubation with anti-ac iculin antibody (Fig. 4,
d an d d ' ). Control immunopr ecipitation with anti-vinculin mAb
revealed seve ra l additiona l bands, besid es vinculin (116 kDa)
and metavinculin (150 kDa ), bu t none of them could be identi-
fied as aciculin (Fig. 4, e and e") ,
Elect rophoresis of 3f>S-labeled immunoprecipitates in 10%
gels allowed resolut ion of at least 3 protein bands in the ran ge
of - 400 kDa in anti-dystrophin, anti-utrophin , and anti-syn-
t rophin immunopr ecipita tes (Fig. 4, b, b' , c, c' , d , and d ' ),
perhap s poin ting to the existence of seve ral dystrophin (utro-
phin) isoforms in C2C 12 myotubes. In terestingly, only two of
them , the fastest and slowest migrati ng dyst roph in bands,
were found in association with aciculin, whereas the middl e
band was missing or barely seen in anti-aciculin immunopre-
cipi ta tes (Fig. 4, a and a' ).
Th e appare nt association of aciculin wit h dystrophin and,
FIG. 4. Aciculin is a major dystrophin-binding protein in cul-
tured d ifferentiated C2C 12 myotubes. RIPA ext rac t of [35SJmethi-
onin e/[5S1cysteine-lab eled differ entiat ed C2C 12 myotubes was pread -
sorbed with unconjugated Seph arose 4B (a ' -e') or with ant i-aciculi n
mAb XIVF8, coupl ed to Seph ar ose 4B (a -e) . Pread sorbed :l5S-labeled
supern ata nts wer e tak en for immunoprecipitation with anti-acic ulin
mAb XIVF8 (a and a ' ), anti-dys t rophin NCL-Dys1 mAb tb and b' ),
anti-utrophin mAb NCL-DRP1 (c and c' ), anti-synt rophin mAb 1351 id
and d ' ), and anti-vincul in mAb VIIF9 (e and e') . Immunoprecipitat es
wer e exte ns ively wash ed with RIPA buffer and run on 10% SDS-poly-
acry lamide gel. Position s of molecular mass markers are give n in kilo-
da lton s to the left of the gel. Note that a major - 60 kDa band, ind icat ed
by the arrow to the left of th e gel, present in ant i-dys trophin tb' ) and
anti -utrophin (c' ) imm un oprecipitates, is deplet ed afte r prein cubati on
wit h anti-aciculin antibody (b and c).
poten ti all y, wit h utrophin , in cu ltured C2C 12 myocytes, urged
us to study whether these cytoskeletal pr oteins are codistrib-
uted in muscle cell cultures. Neither aciculi n nor dyst roph in
were detectable by immuno fluorescence in cult ured C2C 12
myoblasts before cell fusion . Double immunostaining of differ-
ent ia ting C2C 12 cells with rabbit polyclonal anti-aciculin an -
tibodies an d mouse mAbs against dyst roph in reve aled a prec ise
colocalization of these two cytoske letal proteins throughout the
various stages of myocyte differen t ia t ion an d myotube matu -
ration in cult ure following myoblast fusio n (Fig. 5). In ea rly
myotu bes, bot h protein s appeared first at the termini of act in
bundles near the cell t ips (Fig. 5, A an d B ). These structures
correspond to the major cell-matrix attachment sites of cul-
tured myotubes and are homologous to the myotendino us junc-
t ions in t iss ue . More mature, elongated, an d multinucleated
myotubes have both aciculin and dyst rophin colocalized at focal
adhesions (Fig. 5, C and D ). Upon subseque nt growth and
maturation of C2C12 myotubes, aciculi n an d dystrophin were
found redist ribu ted along the stress fiber-like structures in
developing myot ubes (da ta not shown). Finally, in terminally
differen t ia ted cont ractile myotubes, possessing sarcomeric or-
ganization, both aciculin and dystrophi n appeared in a regular
periodic pat tern , corresponding to sarco mere Z-discs (Fig. 5,
E and F ).
In contrast to the dist inct localiza tion of dyst rophin at vari-
ous cell-matrix adherens -ty pe junct ions in cultured mu scle
cells, immunostaining of C2C 12 cultures with the anti-utro-
ph in-specific mAb NCL-DRP I did not reveal any utrophin as -
sociated with stress fiber -like structures, focal adhe sions , or
cell -matr ix attachment site s at the edges of myotubes. Occa-
sional irregul ar bright spots of ut rophi n immunofluor escence
were detecte d in some maturing C2C 12 myotu bes an d were
show n to colocaliz e with clusters of acety lcholine receptors
(da ta not shown). Taken together, our observations indicate
precise colocalization of aciculin and dystrophin in cultured
skeletal musc le cells an d a lack of any codistribution of aciculin
and utroph in in these mu scle cultures.
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FIG. 5. Colocalization of aciculin and dystrophin during myo-
differentiation ofC2C12 cells in culture. C2C12 cells , ta ke n on day
4 (A a nd 8), day 6 (C a nd D ), a nd day 11 (E a nd F ) of cul ture, were
costa ined wit h rabbit polyclonal antibody against aciculin (A, C, a nd E )
and mixture of mouse mAbs against dystrophin (mAbs NC L-Dys 1,
NC L-Dys2, a nd 1808), (B , D , a nd F ). Bar ind icates 20 /lm .
In ske leta l mu scle ti ssu es , both aciculin and dystrophin were
detect ed at th e sarcolemma and at myot endinous junctions
(Fig. 6, A, B, D , and E ), even though aciculin staining at th e
sarcolemma was consid erabl y weak er than that of dystrophin
(Fig. 6, A , B and Refs. 23, 27-30, 33, 34, 57, and 58). In
accordance with ea rlie r obse rvations, utrophin was detected
only very weakl y a t th e sarcolemma (Fig. 6C and Refs. 26 , 63)
and.a t myot endinous junctions (Fig. 6F).
To determine, whether the interaction betw een acicu lin and
dystrophin is du e to th eir direct binding, or mediated by some
oth er protein ts), we subje cte d a mixture of purified aciculin and
dystrophin to gel filtration on a high resolution Superose 6
analytical column. Column fractions were analyze d by SDS-
PAGE and immunoblot ting with ant i-aciculin and anti-dystro-
phin ant ibodies (Fig. 7). When aciculin alone was run through
th e column, the protein was detect ed star ti ng from fraction 32
with most of th e aciculin presen t in fractions 35-47 (Fig. 7A ).
Preincubation of 20 ILg of aciculin with 10 ILg of purified dys-
trophin before th e column run shifte d a detectable proportion of
aciculin toward mu ch higher molecul ar weights on the column
and considerabl e amounts of the protein were detected in the
dystrophin-containing fraction s 25- 32 (Fig. 7B , a and b). A gel
filtration experime nt perform ed wit h a larger am ount of dys-
t rophin (50 ILg ) increased the prop ortion of aciculin in th e high
molecular weigh t fractions (Fig. 7C , a and b ).
Tryin g to identify protein s , associated with aciculin in cells
and ti ssu es outside skeletal mu scle, we prob ed an ti-aciculin
immunoprecipitates from cultured A7r5 smooth muscle cell s,
and REF52 fibr obla sts for th e pr esen ce of utrophin by imrnu-
noblotting (Fig. 8). Indeed , utrophin was det ected in ant i-
aciculin immunoprecipi t ates from both these cell cultures (Fig.
8C, b and c, arrowhead) . Both dystrophin and utroph in were
found in association with aciculin in bovin e heart mu scle t is-
sue , when anti-aciculin immunopr ecipitates were blotted with
anti-dyst rophin (Fig. 8B, a ) and anti-ut rophin (Fig. 8C, a ) an-
tibodies. In contrast, only dystrophin bu t not utrophin was
FIG. 6. Localization of aciculin, dystrophin, and utrophin in
skeletal muscle. 'l -ust» cryosections of adult rab bit skeleta l muscle
(A -C) or chicke n embryonic th igh skeletal mu scle (D -F ) wer e stained
with antibodies against ac iculin (A and D ), dystroph in (B a nd E ), or
ut rophin (C an d F ). M , mu scle; T , te ndon. Bars represent 50 urn (A- C)
or 20 /lm (D-F ).
readily identified in ant i-aciculin immunoprecipitates from
C2C12-cultured myotubes (Fig. 8, B and C, d ). Th erefore, our
results indicate that utrophin , bu t not dystrophin, is assoc iated
with aciculin in cultured smooth mu scle and non mu scle cells . It
should be noted that - 75- 80 kDa immunoreactive bands were
also detected on immunoblots with anti-dys t rophin and anti -
utrophin antibodies (Fig. 8, Band C, asterisks ), suggest ing a
cross-reaction of th ese mAbs with short form s of dystrophin
and/or utrophin (8, 9, 18, 19).
We also analyzed whether aciculin is a maj or utrophin-asso-
ciated protein in cultured A7r5 smooth mu scle cells . An imrnu-
nodepletion experiment was performed with RIPA extracts of
35S-labeled A7r5 cell s (Fig. 9). Pread sorbtion with anti-aciculin
an tibody removed th e majority ofaciculin from celllysates (Fig.
9, a and a', arrow ). A major - 60 kDa protein band, present in
anti-utrophin immunoprecipitates, was shown to represent aci-
culin, since this band was depleted upon pr ein cubati on with
an ti -aciculin mAb XIVF8 (Fig. 9, b and b' , arrow ). Moreover ,
this - 60 kDa band, migrating slightly slower th an the syntro-
phin - 55- 58-kDa doubl et , was also detected in anti-syntrophin
immunopr ecipitates and was noticeabl y depleted aft er pread -
sorbt ion of a cell lysate with XIVF8 mAb (Fig. 9; compare c and
c': th e arrowheads indicate syntrophin), Thi s resul t might be
expla ined by the association of syntrophin with the utrophin
doubl et in cultured A71'5 cells (Fig. 9, c and c' and Ref. 55). Thi s
suggests that the associa tion of aciculin and synt rophin with
utrophin in culture d cells is not mu tually exclus ive and th at
these two utrophin-associated protein s may have non-overlap-
pin g binding sites on the utrophin molecule. In both anti-
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FIG. 7. A d ir ec t interaction between aciculin a nd dystroph in
detected by analytical gel filtration. Western immunoblots with
anti-aciculin mAb XIVF8 show the elut ion pr ofile of 20 f.J.g of aciculin
when chro matographed alone (A) or in the presence of 10 f.J.g (B , b ) or 50
f.J.g (C, b) of purified dyst roph in. Dystrophin-containing fractions in B
and C were visualized by immunoblotting with 1958 mAb (B, a; C, a ).




- 400-kDa protein , iden tifi ed as dyst rophin on immunoblots,
appea red to be a major aciculin-associated protein in cult ured
mu scle cell s. Th e dystrophin-aciculin compl ex is substantia lly
enriche d in the Tri ton X-l OO-insoluble fraction, ind icating its
stable associat ion wit h the actin cytos ke leto n in cultured
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FIG. 9. Aciculin is a major utrophin-binding protein in cul-
tured A7r5 smooth muscle cells. RIPA extracts of [.1.5S1methionine!
[ 3 5S]cysteine-labeled A7r5 cells were preadsorbed with eit her anti-aci-
culin mAb XIVF8, coupled to Sepha rose 4B (c -c), or pla in Sepharose 4B
(a' ·c ' ). Preadsorb ed supernatants wer e taken for immuno precipitation
with anti-aciculin mAb XIVF8 (a and a ' ), anti-utrophin mAb NCL-
DRPI (b and b' ), or anti-syntrophin mAb 1351 (e an d c' ), Immunopre-
cipitates were extensively was hed with RIPA buffer and run on 10%
SDS-polyacrylamide gel. Positions of molecular mass ma rk ers are given
in kilodal tons to the left of the gel. Note, that a major - 60 kDa band,
ind icated by arrow to the left of th e gel, present in anti-utrophin tb' )
and anti-syntrophin (c ') immu noprecipitates, is depleted aft er preincu-
ba tion with the anti-aciculin ant ibody (b and c).Arrowheads point to the
syntro phin doublet aro und - 55- 58 kDa.
FIG. 8. Aciculin is associated with utrophin in cultured A7r5
smooth m uscle cells and REF52 fibroblasts. Anti -aciculin immu-
noprecipitates from bovine heart muscle (a ), A7r5 smooth muscle cells
(b ), REF52 fibroblasts (c), or C2C12 myotu bes (d ) were washed, run on
5- 12% SDS-polyacrylami de gel, transferred to Imm obilon membrane,
and blotted with XIVF8 mAb aga inst aciculin (A), a mixture of mAbs
NCL-Dysl , NCL-Dys2, and 1808 against dystr ophi n (B) or NCL-DRPI
mAb against utr ophin (C). Arrow in A shows the position of aciculin on
the immunoblot. Arrowheads indicate the position of dystrophin (in B )
or utr ophi n (in C) on the immunoblots . H and L designate th e imm u-
noglobulin heavy and ligh t chai ns , respectively. Asterisk s in Band C
mark immunoreactive bands in the ra nge of 75- 80 kDa, cross-reacting
wit h anti-dystrophin (B) and anti-ut rophin (C ) anti bodies.
Vo- 23 25 27 29 31 33 35 37 39 41 43 45 47
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utrophin and anti-syntrophin immunoprecipitates , we were
able to resolve a closely disposed doubl et a round - 400 kDa
(Fig. 9, b, b' , c, and c' ), indicating th e exis te nce of two utrophin
isoforms in A7r5 cult ures. However, only one of these, repre-
senting th e sligh tly faster migrating utrophin va riant, was
detected in associa tion with aciculin (Fig. 9, a and a ' ). Control
immunoprecipitat ion of vinculin or o-actinin from A7r5 cell s
did not reveal any aciculin bound to these two major acti n-
associate d protein s , indica ting specificity for th e obse rved aci-
culin-utrophin copr ecipitation (data not shown). Immunodeple-
tion experiments performed with REF52 cultured cells
revealed simila r , bu t less prominent associat ion of utrophin
wit h aciculin in this cell type (not shown).
DISCUSSION
Recen t work has shown that aciculin is a cyt oskeletal protein
with some sequence homology to PGMl (57). Aciculin is ex-
pr essed primarily in mu scle tiss ues and is associa te d with
adhe re ns junctions and th e act in cytoskeleton (57, 58). Since
aciculin is not an actin-binding protein .f it is important to
determine whi ch protein s are able to interact with aciculin,
linking it to microfilam ents and to peripheral or in tegral mem-
brane components of adhe rens junctions. In the pr esent study,
using immunopr ecipita tion of aciculin from cultured mu scle
cells, we demonstrated that aciculin is associate d with dystro-
phin in ske letal mu scle myotubes. Metab olic lab eling of mu scle
cult ures, followed by immunoprecipi tation, showed that a
c
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C2C 12 cells showed that a major 60 kDa band, coprecipitating
with dystrophin and utrophin, is depleted after preincubation
with anti-aciculin antibodies, therefore identifying aciculin as
one of a few major dystrophin-associated proteins in this cell
type. Taken together, these data point to an association of
aciculin with dystrophin in cultured skeletal muscle cells.
In skeletal muscle tissue, a large transmembrane dystrophin-
glycoprotein complex, containing a 59-kDa triplet of dystrophin-
associated cytoplasmic proteints), was described by Campbell
and co-workers (43, 45, 46, 52). Several lines of evidence sug-
gested that this 59-kDa proteinis) interactts) directly with dys-
trophin, presumably near its C terminus (43, 44, 55, 56). A
58-kDa postsynaptic protein (syntrophin), interacting with dys-
trophin, utrophin, and short C-terminal forms of dystrophin (53,
55, 56), was shown to be structurally and functionally homolo-
gous to one of the recently sequenced proteins in the 59-kDa
triplet, 59-1 DAP (52,54). However, in spite of the similarity in
apparent molecular weight between aciculin and 59-1 DAP (or
syntrophin), it should be noted, that the anti-syntrophin mAb
1351, provided by R. Sealock, did not react with aciculin in
immunoblots. Reciprocally, anti-aciculin mAbs did not recognize
syntrophin," Moreover, none of five anti-aciculin mAbs reacted
with the 59-kDa protein triplet of the dystrophin-glycoprotein
complex, purified from rabbit skeletal muscle sarcolemma."
These facts define aciculin as a new cytoskeletal protein associ-
ated with dystrophin, unrelated to previously described dystro-
phin-associated proteins (43, 47, 52, 55, 56).
Results of analytical gel filtration experiments, obtained in
the present study, show that aciculin is able to interact with
dystrophin directly. Since in vitro experiments have shown
dystrophin to be an actin-binding protein (40), aciculin associ-
ation with actin filaments in muscle cells might be mediated by
dystrophin. By analogy with the erythrocyte membrane skele-
ton, aciculin could stabilize actin-dystrophin interaction at
muscle adhesive contacts, playing a role, similar to that de-
scribed for protein 4.1 in modulating spectrin-actin interaction
(64). In future work, it will be important to determine, whether
aciculin is able to modulate the affinity of dystrophin for actin
in vitro. Potentially, some integral membrane proteins in skel-
etal muscle may interact with aciculin as well, thus providing
another actin-membrane link through dystrophin and dystro-
phin-associated proteins, in skeletal muscle.
At the moment, no precise information concerning the local-
ization of the aciculin-binding site on the dystrophin molecule
is available. However, one observation obtained in this study
indicated that anti-C-terminal anti-dystrophin and anti-utro-
phin mAbs may interfere with aciculin binding to dystrophin
(and utrophin), perhaps pointing to a putative aciculin-binding
site near the dystrophin (and utrophin) C terminus. We did not
detect any association of aciculin with o-actinin or spectrin, two
actin-binding cytoskeletal proteins, sharing some homology
with dystrophin within its N-terminal and central rod domain
(3, 4, 37). Therefore, some indirect evidence may potentially
indicate a localization of the aciculin-binding site within the
cysteine-rich and/or C-terminal domains of dystrophin. Since
extensive alternative splicing of dystrophin pre-mRNA pro-
duces several dystrophin forms differing in their C-terminal
domains (20), and these alternatively spliced dystrophin forms
are expressed in skeletal muscle (12, 20, 23), one cannot ex-
clude the possibility that some dystrophin forms may interact
with 59-1 DAP (syntrophin), whereas others interact with
aciculin.
In the aciculin immunodepletion experiments performed
3 A. M. Belkin, K. Burridge, and R. Sealock, unpublished results.
4 A. M. Belkin, K. Burridge, and K. CampbelI, unpublished results.
with C2C12 myotube extracts, we were able to resolve several
(at least three) high molecular weight bands, likely represent-
ing dystrophin and utrophin alternatively spliced variants. All
these forms were associated with syntrophin, but only two of
them were present in anti-aciculin immunoprecipitates, while
one major dystrophin band was not found in association with
aciculin. This observation suggests preferential binding of aci-
culin to some dystrophin isoforms, while some dystrophin vari-
ants are unable to interact with aciculin. Similarly, the results
of aciculin immunodepletion experiment with A7r5 cell lysate
also showed that utrophin is represented by a closely disposed
doublet in this cell type. Whereas in A7r5 cells syntrophin was
shown to interact with both utrophin forms, having slightly
different mobility on SDS-polyacrylamide gels, aciculin was
found in association only with the faster migrating form. At
present, we do not have any clear explanation for these obser-
vations; however, it is reasonable to suggest that alternative
splicing of utrophin pre-mRNA or post-translational modifica-
tion of utrophin may abolish the aciculin-binding site on the
molecule, generating some utrophin forms unable to interact
with aciculin. Interestingly, our experiments demonstrated the
presence of aciculin in anti-syntrophin immunoprecipitates
from A7r5 cells, also containing significant amounts of utro-
phin. This result indicates that dystrophin and utrophin con-
tain two nonoverlapping binding sites for aciculin and syntro-
phin. Future experiments mapping the aciculin- and
syntrophin-binding sites on dystrophin and utrophin might
help to clarify this point.
Recently, aciculin localization was reported in adherens
junctions of muscle cells during myodifferentiation in culture
(58). Even though dystrophin was localized earlier to focal
adhesions of cultured Xenopus laevis muscle cells (34) and in
web-like surface structures of differentiated chicken myotubes
(65), to our knowledge, this is a first report showing dystrophin
localization at various adherens-type junctions in cultured
muscle cells during reorganization of the actin cytoskeleton
accompanying myogenesis. Earlier, it was reported that the
original C2 mouse muscle cell line expresses only trace, if any,
dystrophin (66, 67). On the contrary, we have detected substan-
tial amounts of dystrophin in the C2C12 subclone of C2 cells,
therefore, allowing us to localize this protein during myodiffer-
entiation in culture and to search for dystrophin-associated
proteins in cultured muscle cells. In C2C12 myocytes, dystro-
phin was localized at myotube tips, transiently at focal contacts
and stress fiber-like structures, and finally at costameres of
differentiated myotubes. Double immunolocalization of acicu-
lin and dystrophin in cultured C2C12 showed that these two
proteins are precisely colocalized throughout all the stages of
actin cytoskeleton reorganization and myofibril assembly, ac-
companying myodifferentiation in culture, thus making their
interaction in cultured muscle cells very likely.
Immunolocalization of both aciculin and dystrophin in skel-
etal muscle tissues revealed codistribution of these two pro-
teins at myotendinous junctions and at the sarcolemma. With
regard to their sarcolemmal localization, both proteins were
shown to be present at skeletal muscle costameres (31, 32, 57,
58). Assuming that aciculin and dystrophin interact in cultured
muscle cells and colocalize at these two types of cell-matrix
adhesive contacts of skeletal muscle fibers, we propose that
myotendinous junctions and, potentially, costameres are the
major sites where the aciculin-dystrophin interaction in skele-
tal muscle might occur. Notably, aciculin is not codistribured
with dystrophin at neuromuscular junctions (58), where other
dystrophin-binding proteins, such as 59-1 DAP (syntrophin),
might link dystrophin and utrophin to the membrane (52, 55).
In our experiments we were able to detect some aciculin
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immunoreactive bands in anti-utrophin immunoprecipitates,
both by immunodepletion experiments and by immunoblotting.
However, it seems unlikely that utrophin is an interactive
partner for aciculin in cultured skeletal muscle myocytes and
skeletal muscle tissue in vivo. First, aciculin shares differenti-
ation-dependent, developmentally regulated expression in
skeletal muscle with dystrophin (14, 58, 68), whereas utrophin
is uniformly expressed during myogenesis (68). Then, we ob-
served an obvious lack of utrophin codistribution with aciculin
both in muscle cultures and tissues, indicating that the two
molecules are not localized at the same intracellular compart-
ment within skeletal muscle fibers. This spatial separation
may not allow them to interact in skeletal muscle.
In contrast to the well established dystrophin expression in
all three muscle types and brain and its obvious lack or ex-
tremely low expression in other tissues (2, 12, 13), aciculin is
synthesized in some nonmuscle tissues and nonmuscle cell
cultures, even though its expression level is much lower when
compared to muscles (57). Looking for aciculin interactive part-
ners in cells and tissues outside skeletal muscle, an obvious
candidate is utrophin which is expressed ubiquitously in non-
muscle tissues and cultured cells (5, 6, 15, 16). Indeed, we
showed that aciculin is associated with utrophin in some cul-
tured cells, namely in A7r5 smooth muscle cells and REF52
fibroblasts. This is not unexpected given that aciculin associ-
ates with dystrophin in skeletal muscle. The prominent struc-
tural similarity between dystrophin and utrophin suggests a
significant overlapping in their functional properties (2, 6, 7,
50,55). For instance, all the dystrophin-associated components
of the sarcolemmal dystrophin-glycoprotein complex were also
found in association with utrophin in skeletal muscle (50). The
58-kDa postsynaptic protein (syntrophin) interacts equally
well with dystrophin, utrophin, or both, depending on the tis-
sue type analyzed (53, 55). Therefore, our data on aciculin
association with utrophin in cultured cells, combined with the
results showing aciculin-dystrophin interaction in skeletal
muscle, give another example of functional conservation be-
tween these two cytoskeletal proteins. As in the case of syntro-
phin association with dystrophin and various dystrophin-
related proteins in different tissues (55), the association of
aciculin with either dystrophin or utrophin appears to be dic-
tated mostly by the expression levels of these proteins in a
given cell type.
In conclusion, we have demonstrated that aciculin is associ-
ated with dystrophin in skeletal muscle and with utrophin in
cultured smooth muscle and fibroblasts. Interaction of aciculin
with dystrophin and utrophin in various cell types might pro-
vide an additional cytoskeletal-matrix link, strengthening the
transmembrane association between the extracellular matrix
and the actin cytoskeleton.
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